+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

IL-1, IL-6 and TNFa activity in children with Kawasaki syndrome before and after treating with intravenous immunoglobulin



IL-1, IL-6 and TNFa activity in children with Kawasaki syndrome before and after treating with intravenous immunoglobulin



9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY [Author] The 9th International Congress of Immunology : 434




(PDF emailed within 1 workday: $29.90)

Accession: 031767684

Download citation: RISBibTeXText


Related references

The effect of intravenous immunoglobulin on lymphocyte populations in children with Kawasaki syndrome. Clinical and Experimental Rheumatology 10(6): 617-620, 1992

Increasing Rate Of Intravenous Immunoglobulin Nonresponders Among Children With Acute Kawasaki Syndrome In San Diego County. Journal of Investigative Medicine 55(1): S122-S123, 2007

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?. Korean Circulation Journal 47(2): 179-181, 2017

Intravenous immunoglobulin in Kawasaki syndrome: a progress report. Pediatric Infectious Disease 5(3 Suppl): S211-S215, 1986

Resistance to intravenous immunoglobulin in children with Kawasaki disease. Journal of Pediatrics 153(1): 117-121, 2008

Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database of Systematic Reviews 2003(4): Cd004000, 2003

Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease. Journal of Pediatrics 163(2): 521-526, 2013

Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease. Journal of the Pediatric Infectious Diseases Society 7(1): 25-29, 2017

Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome. Pediatric Dermatology 30(3): E30-E31, 2014

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial. Bmc Pediatrics 18(1): 200, 2018

Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease. Pediatric Infectious Disease Journal 32(8): E319-E323, 2014

Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease. Zhongguo Dang Dai Er Ke Za Zhi 15(12): 1109-1112, 2014

Effect of intravenous immunoglobulin on neutrophil counts in children with Kawasaki disease. Zhongguo Dang Dai Er Ke Za Zhi 12(12): 991-992, 2016

Efficacy of Four Scoring Systems in Predicting Intravenous Immunoglobulin Resistance in Children with Kawasaki Disease in a Children's Hospital in Beijing, North China. Journal of Pediatrics 184: 120-124, 2017

Acute aseptic meningitis secondary to intravenous immunoglobulin in a patient with Kawasaki syndrome. Pediatric Infectious Disease Journal 17(11): 1054-1056, 1998